Assessment of the Levels of Irisin, Myonectin in Among Patients with Diabetes Type 2 in Kirkuk\Iraq

Abstract

The aim of the current study is to estimate the concentrations of irisin and myonectin in people with type 2 diabetes, and the results of the study showed a significant increase (p≤0.01) in the concentration of irisin in people with type 2 diabetes compared with the healthy group without type 2 diabetes, according to age, the results showed a significant increase(p≤0.01)in the concentration of irisin, especially in the elderly with type 2 diabetes, and on the other hand, the results did not show a significant difference(p≤0.05) in the concentration of irisin in patients with type 2 diabetes who do exercise when compared with those with type 2 diabetes who do not exercise, and the results of the study showed a significant increase (p≤0.01) in the concentration of myonectin in type 2 diabetics compared with the healthy group without type 2 diabetes, according to age, the results showed a significant increase (p≤0.01) in the concentration of myonectin, especially in the elderly with type 2 diabetes, and on the other hand, the results show a significant difference (p≤0.01) in the concentration of myonectin in patients with type 2 diabetes who do exercise when compared to those with type 2 diabetes who do not exercise, and the study concluded that irisin and myonectin have an effect on patients with type 2 diabetes.